UK NSC 2026 call for topics to open on 1 July
UK NSC 2026 call for topics to open on 1 July
The UK National Screening Committee's 2026 call for new screening topics will open on 1 July and close on 30 September.
Consultation opens on population screening for cytomegalovirus
The UK NSC has opened a consultation on evidence relating to antenatal and newborn screening for cytomegalovirus (CMV).
UK NSC consults on evidence related to screening for antenatal and postnatal mental health conditions
The UK National Screening Committee (UK NSC) has opened a consultation on evidence relating to population screening for antenatal and postnatal mental health conditions.
Sign up for UK NSC online seminar on assessing screening programme effectiveness
Posted by:
TJ Day, Posted on:
-
Categories:
Abdominal Aortic Aneurysm Screening, UK National Screening Committee
The UK NSC is holding its next seminar on 1 December, looking at how to assess the effectiveness of screening programmes.
Going Dutch to strengthen international collaboration on screening challenges and opportunities
Members of the UK NSC Secretariat joined experts from the Netherlands, Denmark, Sweden, Iceland, Norway, and the Republic of Ireland at the latest Nordic Screening Network meeting.
UK NSC announces engagement event for organisations developing novel cervical screening tests
The UK National Screening Committee is hosting a roundtable information-sharing event on new technologies relating to cervical screening tests.
UK NSC Blood Spot Task Group work leads to new journal publication
Posted by:
Silvia Lombardo, Posted on:
-
Categories:
Newborn Blood Spot Screening, UK National Screening Committee
Paper explores the challenges, opportunities and practical approaches when developing mathematical models to support policy decisions in newborn blood spot screening.
Analysis of consultation responses gives valuable insight into families’ experiences of congenital CMV
Analysis of UK NSC consultation responses published in journal article.
Tyrosinaemia screening implemented in England
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Behind the scenes with the UK NSC’s Research and Methodology Group
The UK NSC’s Research and Methodology Group has advised on a wide range of screening research projects since its launch.
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
Recent Comments